ClinicalTrials.Veeva

Menu

Sleep Disorders and the Onset and Progression of ALS

P

Peking University

Status

Unknown

Conditions

Amyotrophic Lateral Sclerosis

Treatments

Behavioral: sleep disorder

Study type

Observational

Funder types

Other

Identifiers

NCT04952038
M2020397

Details and patient eligibility

About

200 cases of ALS patients were collected to explore whether sleep disorders are related to earlier onset age, and whether sleep disorders accelerate the progress of ALS and shorten the survival time of ALS patients.

Full description

200 patients with ALS were collected. 1) sleep disorders were assessed by Pittsburgh sleep quality index (PSQI) and Epworth Sleepiness Scale (epworth) at baseline Sleeping Scale,ESS); 2) Name, age, gender and onset site were collected to explore whether sleep disorders were associated with earlier onset age; 3) The patients' function (ALSFRS-R) at baseline and every 3 months within 2 years were collected, and the end-point time (death and invasive breathing) was recorded to evaluate whether sleep disturbance accelerated the decline of patients' function and shortened their short-term survival.

Enrollment

200 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who have been diagnosed in the Department of Neurology of the Third Hospital of Beijing Medical University since August 2020. The clinical diagnosis of patients with amyotrophic lateral sclerosis includes: probable and define;
  • Informed consent has been signed.

Exclusion criteria

  • Those who can not cooperate to complete the scale and receive follow-up.

Trial design

200 participants in 2 patient groups

ALS patients with sleep disorder
Treatment:
Behavioral: sleep disorder
ALS patients without sleep disorder

Trial contacts and locations

1

Loading...

Central trial contact

Dongsheng Fan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems